Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 9/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173043 | 1.00 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL2731647 | 0.94 | FKBP1A (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL4202767 | 0.94 | FKBP1A (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL13601743 | 0.85 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL9657734 | 0.85 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL9657740 | 0.85 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL13601765 | 0.85 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL468767 | 0.82 | FKBP1A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL31632697 | 0.82 | FKBP1A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL468915 | 0.82 | FKBP1A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117363662-B | Saccharomyces cerevisiae fermentation product, preparation method and application thereof | 广州市英朴司生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117363662-B | Saccharomyces cerevisiae fermentation product, preparation method and application thereof | 广州市英朴司生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117363662-A | Saccharomyces cerevisiae fermentation product, preparation method and application thereof | 广州市英朴司生物科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20080268077-A1 | Process for Strengthening the Barrier Function of Undamaged Skin | SYMRISE GMBH & CO. KG (DE) | 2008-10-30 | — | — | US | disclosed |
| CN-1174037-C | Gel composition | �����ɺϻ﹫˾ | 2004-11-03 | — | — | CN | disclosed |
| CN-1134418-C | Substituted pyrazolyl benzenesulfonamides for treating inflammation | - | 2004-01-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268077-A1 | Process for Strengthening the Barrier Function of Undamaged Skin | CERT1, CERS2, SGMS2 | CHRM2 2816/4885CHRM4 3348/4885CHRM5 3746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.